Literature DB >> 30366759

Feasibility and Clinical Efficacy of a Multidisciplinary Home-Telehealth Program to Prevent Falls in Older Adults: A Randomized Controlled Trial.

Palmira Bernocchi1, Alessandro Giordano2, Giuseppe Pintavalle3, Tiziana Galli3, Eleonora Ballini Spoglia3, Doriana Baratti3, Simonetta Scalvini4.   

Abstract

OBJECTIVES: The aim of this study was to determine the feasibility and efficacy of a 6-month tele-rehabilitation home-based program, designed to prevent falls in older adults with 1 or more chronic diseases (cardiac, respiratory, neuromuscular or neurologic) returning home after in-hospital rehabilitation for their chronic condition. Patients were eligible for selection if they had experienced a fall during the previous year or were at high risk of falling.
DESIGN: Randomized controlled trial. Tele-rehabilitation consisted of a falls prevention program run by the physiotherapist involving individual home exercise (strength, balance, and walking) and a weekly structured phone-call by the nurse inquiring about the disease status and symptoms and providing patient support. SETTING AND PARTICIPANTS: Two hundred eighty-three patients (age 79 ± 6.6 years; F = 59%) with high risk of falls and discharged home after in-hospital rehabilitation were randomized to receive home-based program (intervention group, n = 141) or conventional care (control group, n = 142). MEASURES: Incidence of falls at home in the 6-month period (primary outcome); time free to the first fall and proportion of patients sustaining ≥2 falls (secondary outcomes).
RESULTS: During the 6 months, 85 patients fell at least once: 29 (20.6%) in the Intervention Group versus 56 (39.4%) in the control group (P < .001). The risk of falls was significantly reduced in the intervention group (relative risk =0.60, 95% confidence interval: 0.44-0.83; P < .001). The mean ± standard deviation time to first fall was significantly longer in intervention group than control group (152 ± 58 vs 134 ± 62 days; P = .001). Significantly, fewer patients experienced ≥2 falls in the intervention group than in the control group: 11 (8%) versus 24 (17%), P = .020.
CONCLUSIONS: A 6-month tele-rehabilitation home-based program integrated with medical/nursing telesurveillance is feasible and effective in preventing falls in older chronic disease patients with a high risk of falling.
Copyright © 2018 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fall prevention; chronic disease; home tele-rehabilitation; older adults; telemedicine

Mesh:

Year:  2018        PMID: 30366759     DOI: 10.1016/j.jamda.2018.09.003

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  4 in total

Review 1.  Impact of physical activity programs and services for older adults: a rapid review.

Authors:  Marina B Pinheiro; Juliana S Oliveira; Jennifer N Baldwin; Leanne Hassett; Nathalia Costa; Heidi Gilchrist; Belinda Wang; Wing Kwok; Bruna S Albuquerque; Luiza R Pivotto; Ana Paula M C Carvalho-Silva; Sweekriti Sharma; Steven Gilbert; Adrian Bauman; Fiona C Bull; Juana Willumsen; Catherine Sherrington; Anne Tiedemann
Journal:  Int J Behav Nutr Phys Act       Date:  2022-07-14       Impact factor: 8.915

Review 2.  The Impact of the COVID-19 Pandemic on Physical Activity, Function, and Quality of Life.

Authors:  Catherine M Said; Frances Batchelor; Gustavo Duque
Journal:  Clin Geriatr Med       Date:  2022-04-22       Impact factor: 3.529

3.  Editorial: Covid-19 and Virtual Geriatric Care.

Authors:  Reshma A Merchant; I Aprahamian
Journal:  J Nutr Health Aging       Date:  2022       Impact factor: 5.285

4.  Clinical Effects of Outpatient Health Education on Fall Prevention and Self-health Management of Elderly Patients with Chronic Diseases.

Authors:  Yongping Wu; Yueying Gu; Xiuhua Rao; Minling Cheng; Ping Chen; Lina He
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-28       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.